Expert Advice 27 May 2020
Why Listening to Patient Organizations is Key in Drug Development
As the biotech industry flourishes and therapies become more targeted and personalized, the need for drug developers to interact with…
ProQR
- Latest Posts
More News! 11 Oct 2019
RNA Therapy Improves Vision in Untreatable Genetic Blindness
A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the…
Interview 23 Oct 2018
Bridging the Academia-Industry Divide: Lessons from a Serial Biotech Entrepreneur
What does it take to be a successful biotech entrepreneur? I put this and other similar questions to Dinko Valerio,…
News and Trends 5 Sep 2018
RNA Therapy Improves Vision in Patients with Rare Genetic Blindness
Dutch company ProQR has released data from a Phase I/II trial showing its RNA therapy can improve the vision of…
ADVERTISEMENT
Interview 12 Mar 2018
A Dutch Company on the Quest Against Cystic Fibrosis
ProQR is the result of a personal quest against cystic fibrosis started by its CEO, Daniel de Boer. Interested in…
News and Trends 13 Feb 2018
ProQR Tackles Blindness Caused by a Rare Genetic Disease
ProQR has received €6M from the American charity, Foundation Fighting Blindness, for the development of its treatment for Usher Syndrome -…
News and Trends 8 Jan 2018
Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA
Galapagos and ProQR will work together to target fibrosis using a technology to treat genetic diseases without permanent changes to…
News and Trends 30 Nov 2017
RNA Therapy for Rare Skin Disease Gets Orphan Status
The EMA has granted orphan drug designation to ProQR's QR-313, a possible first disease-modifying treatment for the rare disease dystrophic…
News and Trends 14 Nov 2017
Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low
ProQR is aiming to raise funds for clinical trials on the Nasdaq despite the fact that its stock has been…
Interview 25 Oct 2017
What Could RNA Therapies Do for the Treatment of CNS Disorders?
Evelyn chatted with Thomas de Vlaam to find out what his company, Amylon, is working on and how it hopes…
ADVERTISEMENT
More News! 14 Sep 2017
New Dutch Spin Out will Treat Stroke with RNA Therapy
ProQR has spun out Amylon Therapeutics, a company that will treat central nervous system disorders with a lead candidate based…
Best in Biotech 28 Feb 2017
Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden!
Known for its charming canals and tulip fields, Leiden is a major tourist attraction in the Netherlands. It is also home…
News and Trends 19 Aug 2014
ProQR Therapeutics files for a $75m IPO to compete with Vertex Pharmaceuticals
ProQR Therapeutics is a Netherlands-based biotech company focused on developments of drugs to treat genetic disorders. Daniel de Boer, Gerard Platenburg, Dinko…